Ischemic Preconditioning Prevents the Impairment of Hypoxic Coronary Vasodilatation Caused by Ischemia/Reperfusion
- 1 September 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 81 (3) , 415-422
- https://doi.org/10.1161/01.res.81.3.415
Abstract
We previously reported that hypoxic coronary vasodilatation (HCVD) is initiated by endothelial NO and sustained by adenosine. Prolonged ischemia/reperfusion impairs endothelium-dependent coronary vasodilatation, whereas transient ischemia (ie, preconditioning) protects the myocardium from subsequent ischemic events. Accordingly, we assessed whether prolonged ischemia/reperfusion impairs HCVD and whether preconditioning prevents this dysfunction. HCVD, elicited in isolated guinea pig hearts by a 1-minute exposure to 100% N2, consisted of an ≈70% increase in coronary flow associated with enhanced nitrite/nitrate and adenosine overflow (+40% and 5-fold, respectively). After 30-minute global ischemia and 20-minute reperfusion, HCVD was decreased by ≈60%, and the increases in nitrite/nitrate and adenosine overflow were abolished. Preconditioning (ie, three cycles of 5-minute global ischemia+5-minute reperfusion) prevented the impairment of HCVD and fully restored the increase in nitrite/nitrate overflow, but not that of adenosine. The protective effect of preconditioning was mimicked by perfusion with the adenosine A1 receptor agonist N6-cyclopentyladenosine and prevented by the A1 receptor antagonist N-0861. In addition, the A3 receptor agonist N6-(3-iodobenzyl)adenosine-5′-N-methyl-carboxamide had a similar protective effect. The bradykinin B2 receptor antagonist HOE 140 abolished the protective effect of preconditioning, whereas the NO synthase inhibitor Nω-methyl-l-arginine and the cycloxygenase inhibitor indomethacin did not. Our data indicate that preconditioning restores HCVD by a process that is triggered by activation of adenosine A1/A3 and bradykinin B2 receptors. The action of bradykinin is independent of NO and prostacyclin production. Once restored by preconditioning, HCVD is mediated by NO but no longer sustained by adenosine.Keywords
This publication has 24 references indexed in Scilit:
- Does the Antiarrhythmic Effect of Ischemie Preconditioning in Rats Involve the L-Arginine Nitric Oxide Pathway?Journal of Cardiovascular Pharmacology, 1995
- Bradykinin Induces Translocation of the Protein Kinase C Isoforms α, ɛ, and ζEuropean Journal of Biochemistry, 1994
- Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functionsTrends in Pharmacological Sciences, 1994
- Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvementCardiovascular Research, 1994
- Impaired endothelium-dependent relaxation after coronary reperfusion injury: Evidence for G-protein dysfunctionThe Annals of Thoracic Surgery, 1994
- Evidence that Translocation of Protein Kinase C is a Key Event During Ischemic Preconditioning of Rabbit MyocardiumJournal of Molecular and Cellular Cardiology, 1994
- Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitationTrends in Pharmacological Sciences, 1994
- Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoidsCardiovascular Research, 1992
- Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro.Journal of Clinical Investigation, 1987
- Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs.Journal of Clinical Investigation, 1975